Mural Oncology
MA - WalthamBiotechnology
Focus: Mural Oncology is a Waltham-based immunotherapy-focused biotech developing novel cancer treatments, primarily in early-to-mid stage clinical development. The company is actively hiring across product, IT, and revenue functions, signaling active growth.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
10-2 this month
Stable — net -2 jobs in 30d
4 added, 6 removed. Backfill posture.
Should You Work at Mural Oncology?
AI assessmentEarly-stage immunotherapy play with solid clinical depth but unproven financial stability; best suited for risk-tolerant candidates seeking hands-on pipeline experience.
Why Work Here
- Early-stage immunotherapy platform with 6 active clinical programs across Phase 1/2/3, offering broad exposure to oncology mechanism development
- Active hiring (9 open roles) concentrated in Product and IT, indicating runway and investment in core infrastructure
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ALKS 4230
Advanced Solid TumorsClinical Trials (1)
NCT03861793A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)
Phase 1/2Help build intelligence for Mural Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.